Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Institutional Investor Meeting25-11-2020
25-11-2020
Gland Pharma stock rallies 7%, up 47 % over issue price
The stock was listed on November 20, and since then has ended lower in one session.25-11-2020
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meetings21-11-2020
Gland Pharma makes strong market debut on Friday, stock rises 21%
The post-listing market capitalisation for the company stands at Rs 29,848 crore, helping it break into the top 10 valuable pharma firms in the country20-11-2020
Gland Pharma Ltd - 543245 - Listing of equity shares of Gland Pharma Ltd
Trading Members of the Exchange are hereby informed that effective from November 20, 2020, the equity shares of Gland Pharma Ltd (Scrip Code: 543245) are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. For further details please refer to the notice no 20201119-24 dated November 19, 2020.20-11-2020
Subscribe to Gland Pharma: Nirmal Bang
Nirmal Bang has come out with its report on Gland Pharma. The research firm has recommended to ''Subscribe'' the ipo in its research report as on November 09, 202010-11-2020
Gland Pharma opens for subscription today: Should you subscribe?
The shareholding of promoters - Fosun Singapore and Shanghai Fosun Pharma - in the company will be reduced to around 58 percent from 74 percent now.09-11-2020